neoplastic condition of the erythroblastic portion of the bone-marrow was accompanied by a corresponding non-malignant neoplastic condition of the leucoblastic portion of the bonemarrow. Such cases were, in fact, examples of what might be termed non-malignant erythroleukaemia. The very rare supervention in such cases of true myelosis (myeloid leukwemia) would therefore signify that the non-malignant leucoblastic factor of the erythroleukEemia syndrome had taken on the malignant neoplastic character of full-blown myeloid leukEemia, whereas at first it corresponded to the (very rare) so-called polymorphonuclear neutrophil variety or stage of myeloid leukoemia. In cases of erythro-leukaemia why was it that the erythroblastic factor never manifested an analogous malignant transformation ?
Erythr8emic splenomegaly seemed to be mainly connected with the blood-reservoir function of the spleen. In rare cases of true erythrEemia (and of course in all cases of Giesbock's "polycythemia hypertonica"), especially in patients who were not of the usual lean type, there might be no obvious splenomegaly.
In regard to the diagnosis of atypical forms of erythremia the occasional occurrence of what might be termed " symptomatic " splenomegalic polycythemia should be kept in mind. Thus polycythemia might occasionally accompany the splenomegaly of splenic tuberculosis and the splenomegaly of obstructive conditions in the portal and hepatic veins (including probably the very rare "Chiari's disease ") and the splenomegaly of obscure cases incorrectly supposed to be cases of " splenic mycosis," or resembling splenic anaemia or Banti's disease (but with polycythaemia instead of anemia).
Amongst the complications of erythrEemia which Dr. Weber had especially observed were: (1) Recurrent gout and tophaceous deposits; (2) uric acid lithiasis (obviously comparable to the similar occasional complication of myeloid leukemia); (3) hEematuria; (4) tortuosity of arteries; (5) thrombo-angiitis obliterans of extremities; (6) erythro-melalgia; (7) haematemesis without obvious gastric or duodenal ulcer, though actual duodenal ulceration undoubtedly sometimes occurred; (8) attacks of sudden or subacute cardiac incompetence; (9) hepatic cirrhosis; (10) cerebral strokes, probably of thrombotic origin; (11) During the treatment, the blood-platelets were counted and no abnormal rise was found. The urine was examined repeatedly for urobilin and urobilinogen; very slight traces of urobilinogen (Ehrlich) were found both before and during phenylhydrazine treatment; no urobilin or.bile-pigments were found on any occasion. Patient feels herself to be very much better and now walks about with confidence.
Summary.-The patient, in whom two courses of treatment with X-rays had failed to produce effect, and who was unrelieved by venesections, has shown a satisfactory response to phenylhydrazine in doses of 1P5 gr. twice weekly (0-1 grm.), without any evidence of toxic reaction or excessive blood destruction. It is suggested that these minimal doses should be tried in all cases and the dose only increased if necessary, after six or eight weeks' treatment.
